Trials / Completed
CompletedNCT01578421
Investigation on the Middle Size Molecule Elimination Characteristics of the FXCorDiax 100 in Relation to the FX 100 and the Polyflux 210 H Dialyser
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Kantonsspital Aarau · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to compare clearance and removal rates of phosphate, ß2-microglobulin (ß2-m) and leptin and albumin loss with different dialyser membranes during post-dilution online hemodiafiltration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 4 h online hemodiafiltration (FX 100, Polyflux 210, FXCorDiax) | 4 h online hemodiafiltration with measurement of clearance and removal rate by split dialysate collection and bloodside measurements |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2012-09-01
- Completion
- 2012-12-01
- First posted
- 2012-04-17
- Last updated
- 2013-08-07
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01578421. Inclusion in this directory is not an endorsement.